Gevorg Grigoryan
Gevorg Grigoryan is co-founder and chief technology officer of Generate:Biomedicines, whose platform generates new drugs on demand. He completed a PhD at MIT in 2007, joined Dartmouth in 2011 after a postdoc at the University of Pennsylvania, and won a Sloan Research Fellowship in 2013. He co-founded Generate:Biomedicines with Noubar Afeyan and others. In 2023 he co-authored a Nature paper that introduced Chroma, a generative model for proteins. In 2026 the company completed an initial public offering that raised about $400 million.
- Now at
- Generate:Biomedicines and Dartmouth College
- Works
- 81
- Citations
- 3,657
- h-index
- 29
Publication numbers from OpenAlex, as of 15 October 2026.
Timeline
-
2007
A doctorate at MIT
He completes a PhD at MIT in 2007.
-
2011
Joining the Dartmouth faculty
He joins Dartmouth in 2011, after a postdoc at the University of Pennsylvania with William DeGrado.
-
2013
A Sloan Research Fellowship
A Sloan Research Fellowship goes to him in 2013.
-
2017
Tenure at Dartmouth
In 2017 he receives tenure at Dartmouth.
-
2023
The Chroma generative model
The 2023 Nature paper introducing Chroma, a generative model for proteins, lists him as a co-author.
-
2026
An initial public offering
In 2026 Generate:Biomedicines completes its initial public offering, raising about $400 million.
-
As of October 2026
Chief technology officer at Generate
He is co-founder and chief technology officer of Generate:Biomedicines, where he leads development of the Generate Platform, an integrated system for generating new drugs on demand. He co-founds the company with Noubar Afeyan and others.
Sources and credits
Photo: We have no published photo of Gevorg Grigoryan yet. Send us a free-licensed photo.